Hydroxychloroquine (with or without azithromycin) has received a lot of media attention for the treatment of COVID-19, but is there evidence that it works?
An EBM Perspective on Hydroxychloroquine and Azithromycin for the Treatment of COVID-19
April 27, 2020
Patients with pre-existing conditions are at a higher risk for severe COVID-19. Read about considerations for certain high-risk patient populations during the pandemic.
Considerations for COVID-19 in Patients with Pre-existing High-risk Conditions
April 16, 2020
In this unique EBM Focus article, the DynaMed team answers ten frequently asked questions about coronavirus disease 2019 (COVID-19).
COVID-19: Ten Things You Need to Know
April 09, 2020
What’s on the horizon beyond infection prevention and supportive care for COVID-19? Read about some of the drugs in clinical trials.
Potential Therapeutic Options in COVID-19 Clinical Trials
April 08, 2020
Read about the development of a COVID-19 information portal from Brian S. Alper, MD, MSPH, FAAFP, FAMIA.
The Development of a COVID-19 Information Portal
March 31, 2020
Read about the clinical progression of COVID-19 and the recovery rate and process.
Clinical Progression and Recovery of Patients with COVID-19
March 19, 2020
In this EBM Focus, a new evaluation of isolated diastolic hypertension (IDH) in the U.S. shows higher prevalence with the AHA/ACC definition compared to JNC7, but no difference in mortality.
EBM Focus: In Another Episode of Overdiagnosis…
March 18, 2020
Read about the challenges of reporting on the novel coronavirus (COVID-19) outbreak from the Infectious Disease publishing group at DynaMed.
How a Clinical Resource Handles an Emerging Public Health Crisis — The Story of Novel Coronavirus
March 11, 2020
DynaMed founder Brian S. Alper, MD, MSPH, FAAFP, FAMIA is the new Chief Medical Knowledge Officer at EBSCO Information Services. Read about this new role.
Meet DynaMed Founder Brian S. Alper, Now Chief Medical Knowledge Officer at EBSCO
March 09, 2020
A new study evaluates aspirin for secondary prevention of cardiovascular disease among a more racially diverse population than previous studies.
EBM Focus: Take Two-Seven Aspirin and Call Me in a Week
March 04, 2020
© 2020 EBSCO Information Services. All rights reserved